BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gupta P, Soundararajan R, Patel A, Kumar-M P, Sharma V, Kalra N. Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis. J Hepatol 2021;75:108-19. [PMID: 33548385 DOI: 10.1016/j.jhep.2021.01.041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Soundararajan R, Gupta P. Reply to "Abbreviated MRI to screen for HCC in patients with cirrhosis. A step forward but a long road ahead". J Hepatol 2021:S0168-8278(21)02292-3. [PMID: 34954247 DOI: 10.1016/j.jhep.2021.12.017] [Reference Citation Analysis]
2 Park HJ, Kim SY, Singal AG, Lee SJ, Won HJ, Byun JH, Choi SH, Yokoo T, Kim MJ, Lim YS. Abbreviated magnetic resonance imaging vs ultrasound for surveillance of hepatocellular carcinoma in high-risk patients. Liver Int 2021. [PMID: 34817921 DOI: 10.1111/liv.15110] [Reference Citation Analysis]
3 Singal AG, El-Serag HB. Rational HCC screening approaches for patients with NAFLD. J Hepatol 2021:S0168-8278(21)02026-2. [PMID: 34508791 DOI: 10.1016/j.jhep.2021.08.028] [Reference Citation Analysis]
4 Lok J, Agarwal K. Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update. Viruses 2021;13:1333. [PMID: 34372539 DOI: 10.3390/v13071333] [Reference Citation Analysis]
5 Kim DH, Choi SH, Shim JH, Kim SY, Lee SS, Byun JH, Choi JI. Meta-Analysis of the Accuracy of Abbreviated Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance: Non-Contrast versus Hepatobiliary Phase-Abbreviated Magnetic Resonance Imaging. Cancers (Basel) 2021;13:2975. [PMID: 34198589 DOI: 10.3390/cancers13122975] [Reference Citation Analysis]
6 Nadarevic T, Colli A, Giljaca V, Fraquelli M, Casazza G, Manzotti C, Štimac D, Miletic D. Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database Syst Rev 2022;5:CD014798. [PMID: 35521901 DOI: 10.1002/14651858.CD014798.pub2] [Reference Citation Analysis]
7 Kutaiba N, Ardalan Z. Risk factors and screening intervals are crucial to evaluating the cost effectiveness of abbreviated MRI in HCC screening. J Hepatol 2021:S0168-8278(21)01892-4. [PMID: 34242701 DOI: 10.1016/j.jhep.2021.06.041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Gupta P, Sharma V, Kalra N. Reply to: "Risk factors and screening intervals are crucial for evaluating the cost effectiveness of abbreviated MRI in HCC screening". J Hepatol 2021;75:1259-60. [PMID: 34437909 DOI: 10.1016/j.jhep.2021.08.002] [Reference Citation Analysis]
9 Kim DH, Choi SH, Lee JS, Choi JI. Inter-reader agreement of abbreviated magnetic resonance imaging for hepatocellular carcinoma detection: a systematic review and meta-analysis. Abdom Radiol (NY) 2022;47:123-32. [PMID: 34633497 DOI: 10.1007/s00261-021-03297-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Granata V, Grassi R, Fusco R, Setola SV, Belli A, Piccirillo M, Pradella S, Giordano M, Cappabianca S, Brunese L, Grassi R, Petrillo A, Izzo F. Abbreviated MRI Protocol for the Assessment of Ablated Area in HCC Patients. Int J Environ Res Public Health 2021;18:3598. [PMID: 33808466 DOI: 10.3390/ijerph18073598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Pavlides M, Francis S, Barnes E. Abbreviated MRI to screen for HCC in patients with cirrhosis. A step forward but a long road ahead. J Hepatol 2021:S0168-8278(21)02169-3. [PMID: 34762998 DOI: 10.1016/j.jhep.2021.10.027] [Reference Citation Analysis]
12 Melendez-Torres J, Singal AG. Early detection of hepatocellular carcinoma: roadmap for improvement. Expert Rev Anticancer Ther 2022. [PMID: 35514249 DOI: 10.1080/14737140.2022.2074404] [Reference Citation Analysis]
13 Nahon P, Najean M, Layese R, Zarca K, Segar LB, Cagnot C, Ganne-Carrié N, N'Kontchou G, Pol S, Chaffaut C, Carrat F, Ronot M, Audureau E, Durand-Zaleski I; ANRS CO12 CirVir., ANRS CO22 Hepather., Scientific Committee – Voting members., CIRRAL groups. Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis. JHEP Rep 2022;4:100390. [PMID: 34977518 DOI: 10.1016/j.jhepr.2021.100390] [Reference Citation Analysis]
14 An J. [Current Status and Future Directions of Hepatocellular Carcinoma Surveillance Test Based on Cost-effective Analysis]. Korean J Gastroenterol 2021;78:255-60. [PMID: 34824183 DOI: 10.4166/kjg.2021.142] [Reference Citation Analysis]
15 Bansal A, Ramegowda R, Gupta P, Shah J, Samanta J, Mandavdhare H, Sharma V, Kochhar R, Sandhu MS. Abbreviated non-enhanced magnetic resonance imaging in patients with acute necrotizing pancreatitis. Abdom Radiol (NY) 2022. [PMID: 35507068 DOI: 10.1007/s00261-022-03531-3] [Reference Citation Analysis]
16 Philips CA, Rajesh S, Nair DC, Ahamed R, Abduljaleel JK, Augustine P. Hepatocellular Carcinoma in 2021: An Exhaustive Update. Cureus 2021;13:e19274. [PMID: 34754704 DOI: 10.7759/cureus.19274] [Reference Citation Analysis]